INDIA’S FIRST AYURVEDIC ANTI-DIABETIC MOLECULE LAUNCHED IN KOLKATA

By Swarnali Goswami (TNI Kolkata)  |  Edited By R. Subrata (TNI Siliguri)

Webdesk, TNI Kolkata 30^th May, 2016: Council for Scientific and Industrial Research (CSIR) and National Botanical Research Institute (NBRI) today jointly announced the launch of the India’s first Ayurvedic anti-diabetic molecule BGR- 34 with DPP inhibitory Activity at The Park in Kolkata. BGR (Blood Glucose Regulator)-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP) as well as the research units of CSIR, Govt. of India situated at Lucknow. The drug is designed for type 2 Diabetes mellitus has been scientifically validated for its efficacy and safety. It is now available on all major chemist counters of India. 6 best herbs listed in Ayurvedic ancient texts for various ailments and indications namely Daruharidra, Giloy, Vijaysar, Gudmar, Majeeth, and Methika are combined in different fractions & quantity and processed meticulously to develop this marvelous anti-diabetic formulation. For the purpose of quality, commercial production and extended distribution of the drug the rights & technical know-how has been transferred to AIMIL Pharmaceuticals (I) Ltd. for large scale production and marketing. AIMIL Pharmaceuticals is well known for its innovative quality Herbal / Ayurvedic products in the market. BGR-34 has been economically priced at Rs. 5 per tablet as compared to latest DPP4 inhibitors globally. During the launch Dr. A.K.S. Rawat, Senior Principal Scientist of CSIR-NBRI said, “The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs.” Dr. Ch V. Rao, Principal Scientist CSIR-NBRI in this occasion said, “The product is passed through several series of tests and it has shown hypoglycemic activity in experimental subjects.”

Photo: Swarnali Goswami (TNI)